Verseon Presents New Efficacy Results on Oral Diabetic Macular Edema Drug Candidate at Vision and Ophthalmology Conference
FREMONT, Calif.--(BUSINESS WIRE)--Verseon presented new efficacy results on its diabetic macular edema drug candidates at the ARVO conference this week.